Elizabeth R Woodruff

13PUBLICATIONS
56CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 24, 2026
Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor.

Tomomi M Yamamoto, Ritsuko Iwanaga, Elizabeth R Woodruff

|Dec 04, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto

|Dec 03, 2024
Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival.

Fabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda

|Sep 16, 2024
Claudin-4 remodeling of nucleus-cell cycle crosstalk maintains ovarian tumor genome stability and drives resistance to genomic instability-inducing agents.

Fabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda

|Aug 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.

Lily L Nguyen, Zachary L Watson, Raquel Ortega

|Jul 10, 2024
Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Carcinoma.

Ritsuko Iwanaga, Tomomi M Yamamoto, Karina Gomez

Pageof 3